Black Diamond Therapeutics BDTX
NASDAQ BDTX
$2.08 +0.01 (+0.48%)
At close: Oct 21, 2026 · 4:00 PM EDT

Black Diamond Therapeutics (BDTX) Preferred Stock Liabilities (2018 - 2019)

Updated

Black Diamond Therapeutics' Preferred Stock Liabilities came in at $200.57 million for Q4 2019, up 230.1% from $60.77 million a year earlier and up 73.1% from the prior quarter.

Analysis

Black Diamond Therapeutics (BDTX) Preferred Stock Liabilities (2018 - 2019) Analysis & Trends

Going back to Q4 2018, Black Diamond Therapeutics' Preferred Stock Liabilities data covers 5 quarters.

  • Going back by year, Preferred Stock Liabilities was $60.77 million in FY2018.
  • Business Quant data shows BDTX's Preferred Stock Liabilities at $115.84 million (Q3 2019), $60.77 million (Q2 2019) and $60.77 million (Q1 2019) in the three quarters before Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Black Diamond Therapeutics 118.75 Mn -374.17 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 200.57 Mn
Sep 30, 2019 115.84 Mn
Jun 30, 2019 60.77 Mn
Mar 31, 2019 60.77 Mn
Dec 31, 2018 60.77 Mn
API Access

Black Diamond Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=BDTX&period=max&api_key=YOUR_API_KEY